Sie, P., Caron, C., Azam, J., Goudemand, J., Grandjean, H., Boneu, B., et al. (2003) Reassessment of von Willebrand Factor (VWF), VWF Propeptide, Factor VIII: C and Plasminogen Activator Inhibitors 1 and 2 during Normal Pregnancy. British Journal of Haematology, 121, 897-903. https://doi.org/10.1046/j.1365-2141.2003.04371.x

has been cited by the following article:

• TITLE: Recurrent Cyst within Willebrand Disease: Place of Surgery?

  AUTHORS: Meriem Nafidi, Amal Khald, Abderrahim Aboulfalah, Abderraouf Soummani

  KEYWORDS: Willebrand Disease, Recurrent Ovarian Cyst, Medical Treatment

  JOURNAL NAME: Open Access Library Journal, Vol.9 No.6, June 8, 2022

  ABSTRACT: Von Willebrand factor is a multimeric glycoprotein that plays an essential role in platelet-rich thrombi formation under high shear stress. The heterogeneity of Von Willebrand disease (vWD) illustrates the complex physiology of this protein. For women, menstrual patterns and heavy menstrual bleeding are the most frequent disorders within the inherited bleeding disorders population. Pelvic pain due to recurrent hemorrhagic ovarian cyst does not appear to have a higher frequency in the vWD population. Though, it can be a source of impaired quality of life and many invasive procedures. In this report, we will describe the management of a recurrent ovarian cyst and show the importance of medical/conservative treatment without loaning to surgery.